Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Milestone Pharmaceuticals Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 43 | 47 | +4 |
| Shares | 28.7M | 24.6M | −4.13M (−14.4%) |
| Value | $43.6M | $57.9M | +$14.4M (+32.9%) |
New holders (10)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Toronto Dominion Bank | 750,000 | $1.77M | 0.00% |
| Boxer Capital Management, LLC | 309,007 | $729.3K | 0.06% |
| UBS Group AG | 89,506 | $211.2K | 0.00% |
| Virtu Financial LLC | 71,955 | $170.0K | 0.01% |
| Group One Trading, L.P. | 52,637 | $124.2K | 0.00% |
| XTX Topco Ltd | 34,054 | $80.4K | 0.01% |
| Susquehanna International Group, LLP | 33,092 | $78.1K | 0.00% |
| Cubist Systematic Strategies, LLC | 30,938 | $73.0K | 0.00% |
| JPMorgan Chase & Co | 900 | $2.12K | 0.00% |
| Citigroup Inc | 329 | $776 | 0.00% |
Sold out (6)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Altium Capital Management LP | 440,000 | $668.8K |
| Boxer Capital, LLC | 309,007 | $469.7K |
| PVG Asset Management Corp | 30,345 | $46.1K |
| ADAR1 Capital Management, LLC | 27,931 | $42.5K |
| Engineers Gate Manager LP | 11,074 | $16.8K |
| Royal Bank of Canada | 800 | $1.00K |